| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2720244 | The American Journal of Medicine | 2009 | 11 Pages |
Abstract
Our results add strength to the hypothesis that the combination of ribavirin and corticosteroids has no therapeutic benefit when given early during severe acute respiratory syndrome infection. Further studies may investigate the effects of these treatments later in disease course.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Eric H.Y. PhD, Benjamin J. PhD, Matthew P. MD, FRCPC, Lai-Ming PhD, Thomas MBBS, MPH, Su-Vui MBChB, FRCP, Marie MD, FRCPC, Gabriel M. MD, MPH,